David Einhorn GANX Holdings History
David Einhorn's Gain Therapeutics Inc Holding Summary
As of 2025-03-31, Greenlight Capital held 566,130.00 shares of Gain Therapeutics Inc(GANX), totaling $1.08 Mil. This investment constitutes 0.05% of their stock portfolio, and Greenlight Capital now holds 1.92% of the outstanding Gain Therapeutics Inc(GANX) stock.
The initial trade took place in 2021Q1. And since then David Einhorn has made 2 purchases of GANX, at an average price of $12.46, for a total of 588,410.00 shares. In addition, there have been 1 sales at an average price of $4.15 for 22,280.00 shares. Based on historical transaction data and GANX's current price of $1.69, David Einhorn's estimated gain on his GANX holdings is $-6.28 Mil, reflecting a -85.68% gain to date.
David Einhorn GANX ($1.69) Holding Chart
David Einhorn GANX ($1.69) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
